» Articles » PMID: 33267664

Endothelial Rap1 (Ras-Association Proximate 1) Restricts Inflammatory Signaling to Protect From the Progression of Atherosclerosis

Overview
Date 2020 Dec 3
PMID 33267664
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Small GTPase Rap1 (Ras-association proximate 1) is a novel, positive regulator of NO release and endothelial function with a potentially key role in mechanosensing of atheroprotective, laminar flow. Our objective was to delineate the role of Rap1 in the progression of atherosclerosis and its specific functions in the presence and absence of laminar flow, to better define its role in endothelial mechanisms contributing to plaque formation and atherogenesis. Approach and Results: In a mouse atherosclerosis model, endothelial Rap1B deletion exacerbates atherosclerotic plaque formation. In the thoracic aorta, where laminar shear stress-induced NO is otherwise atheroprotective, plaque area is increased in Athero-Rap1B (atherogenic endothelial cell-specific, tamoxifen-inducible Rap1A+Rap1B knockout) mice. Endothelial Rap1 deficiency also leads to increased plaque size, leukocyte accumulation, and increased CAM (cell adhesion molecule) expression in atheroprone areas, whereas vascular permeability is unchanged. In endothelial cells, in the absence of protective laminar flow, Rap1 deficiency leads to an increased proinflammatory TNF-α (tumor necrosis factor alpha) signaling and increased NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) activation and elevated inflammatory receptor expression. Interestingly, this increased signaling to NF-κB activation is corrected by AKTVIII-an inhibitor of Akt (protein kinase B) translocation to the membrane. Together, these data implicate Rap1 in restricting Akt-dependent signaling, preventing excessive cytokine receptor signaling and proinflammatory NF-κB activation.

Conclusions: Via 2 distinct mechanisms, endothelial Rap1 protects from the atherosclerosis progression in the presence and absence of laminar flow; Rap1-stimulated NO release predominates in laminar flow, and restriction of proinflammatory signaling predominates in the absence of laminar flow. Our studies provide novel insights into the mechanisms underlying endothelial homeostasis and reveal the importance of Rap1 signaling in cardiovascular disease.

Citing Articles

The functions of immune system-derived miRNAs in cardiovascular diseases.

Sufianov A, Agaverdiev M, Mashkin A, Ilyasova T Noncoding RNA Res. 2024; 11:91-103.

PMID: 39736852 PMC: 11683256. DOI: 10.1016/j.ncrna.2024.11.004.


Towards Targeting Endothelial Rap1B to Overcome Vascular Immunosuppression in Cancer.

Ghadrdoost Nakhchi B, Kosuru R, Chrzanowska M Int J Mol Sci. 2024; 25(18).

PMID: 39337337 PMC: 11432579. DOI: 10.3390/ijms25189853.


Rap1A Modulates Store-Operated Calcium Entry in the Lung Endothelium: A Novel Mechanism Controlling NFAT-Mediated Vascular Inflammation and Permeability.

Kosuru R, Romito O, Sharma G, Ferraresso F, Ghadrdoost Nakhchi B, Yang K Arterioscler Thromb Vasc Biol. 2024; 44(11):2271-2287.

PMID: 39324266 PMC: 11495542. DOI: 10.1161/ATVBAHA.124.321458.


Relationship between LDL-cholesterol, small and dense LDL particles, and mRNA expression in a cohort of African Americans.

Diallo A, Abbas M, Goodney G, Price E, Gaye A Am J Physiol Heart Circ Physiol. 2024; 327(3):H690-H700.

PMID: 39028281 PMC: 11901346. DOI: 10.1152/ajpheart.00332.2024.


Network pharmacology and in vivo evidence of the pharmacological mechanism of geniposide in the treatment of atherosclerosis.

Ma G, Dong Q, Li F, Jin Z, Pi J, Wu W BMC Complement Med Ther. 2024; 24(1):53.

PMID: 38267978 PMC: 10807192. DOI: 10.1186/s12906-024-04356-x.


References
1.
Robinet P, Milewicz D, Cassis L, Leeper N, Lu H, Smith J . Consideration of Sex Differences in Design and Reporting of Experimental Arterial Pathology Studies-Statement From ATVB Council. Arterioscler Thromb Vasc Biol. 2018; 38(2):292-303. PMC: 5785439. DOI: 10.1161/ATVBAHA.117.309524. View

2.
Kuhlencordt P, Gyurko R, Han F, Scherrer-Crosbie M, Aretz T, Hajjar R . Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice. Circulation. 2001; 104(4):448-54. DOI: 10.1161/hc2901.091399. View

3.
Yang H, Liang Y, Wu Y, Chung C, Chiang K, Ho H . Genome-wide association study of young-onset hypertension in the Han Chinese population of Taiwan. PLoS One. 2009; 4(5):e5459. PMC: 2674219. DOI: 10.1371/journal.pone.0005459. View

4.
Chiu J, Chien S . Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives. Physiol Rev. 2011; 91(1):327-87. PMC: 3844671. DOI: 10.1152/physrev.00047.2009. View

5.
Herrmann C . Ras-effector interactions: after one decade. Curr Opin Struct Biol. 2003; 13(1):122-9. DOI: 10.1016/s0959-440x(02)00007-6. View